Pacific Biosciences of California, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Pacific Biosciences of California, Inc. (PACB) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $0 as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2026-02-25
- 2025-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2025-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2025-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2025-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 |
| 2024-12-31 | $18.70M 10-K · filed 2026-02-25 |
| 2024-09-30 | $20.65M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $19.48M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $19.48M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $19.55M 10-K · filed 2025-03-17 |
| 2023-09-30 | $18.45M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $186.32M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $184.35M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $172.09M 10-K · filed 2024-02-28 |
| 2022-09-30 | $167.50M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $163.22M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $168.65M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $169.72M 10-K · filed 2023-02-28 |
| 2021-09-30 | $168.57M 10-Q · filed 2021-11-05 |
| 2018-12-31 | $16.00K 10-K · filed 2020-02-28 |
| 2018-09-30 | $28.00K 10-Q · filed 2018-11-05 |
| 2018-06-30 | $40.00K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $12.00K 10-Q · filed 2018-05-02 |
| 2017-12-31 | $183.00K 10-K · filed 2019-02-26 |
| 2017-09-30 | $170.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $15.00K 10-Q · filed 2017-08-02 |
| 2017-03-31 | $208.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $356.00K 10-K · filed 2018-02-26 |
| 2016-09-30 | $218.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $264.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $551.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $600.00K 10-K · filed 2017-03-06 |
| 2014-12-31 | $944.00K 10-K · filed 2016-03-11 |
| 2014-09-30 | $699.00K 10-Q · filed 2014-11-05 |
| 2014-06-30 | $699.00K 10-Q · filed 2014-08-05 |
| 2014-03-31 | $549.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $549.00K 10-K · filed 2015-03-12 |
| 2013-09-30 | $894.00K 10-Q · filed 2013-11-12 |
| 2013-03-31 | $999.00K 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |